XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income (loss) $ (850) $ 29,354 $ (21,006)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Amortization and depreciation 8,398 10,414 7,027
Amortization of debt issuance costs 41 142 217
Gross proceeds from sale of renewal rights (30,000) (28,000) 0
Impairment loss on right of use lease assets 488 1,515 0
Impairment loss on software 508 2,000 0
Impairment loss on goodwill and intangible assets 5,657 1,295 0
Restricted stock and stock option expense 3,899 2,355 6,774
Deferred federal income taxes 2,395 3,395 (8,268)
Amortization of bond premium and discount, net 1,267 6,509 6,957
Net realized investment (gains) losses 32,929 (15,887) 14,662
Loss on extinguishment of debt 3,529 0 3,060
(Income) loss from equity method investments, net of distributions 6,549 (2,716) 6,346
Changes in:      
Premium receivables, net (40,299) (19,013) 8,604
Reinsurance receivables, net 14,143 (11,156) (4,770)
Funds held by ceding insurers 8,785 17,216 4,294
Unpaid losses and loss adjustment expenses 72,500 97,093 32,630
Unearned premiums (47,213) 25,071 (23,366)
Ceded balances payable (18,099) 26,397 (11,461)
Other assets and liabilities (12,814) (16,507) (8,240)
Contingent commissions 913 (2,929) (1,096)
Federal income tax receivable/payable 0 0 10,989
Deferred acquisition costs (4,563) 4,864 5,482
Prepaid reinsurance premiums 36,073 (40,613) 3,835
Net cash provided by operating activities 44,236 90,799 32,670
Cash flows from investing activities:      
Proceeds from sale of fixed maturities 933,554 1,065,398 791,554
Proceeds from sale of equity securities 88,726 54,691 604,772
Proceeds from maturity of fixed maturities 81,546 87,057 119,326
Proceeds from maturity of preferred stock 1,000 666 0
Proceeds from other invested assets 107,925 17,082 4,211
Amounts received (paid) in connection with derivatives 12,726 2,723 (20,456)
Purchases of fixed maturities (1,164,683) (1,207,231) (808,618)
Purchases of equity securities (10,660) (42,905) (455,907)
Purchases of other invested assets 0 (70,000) (60,297)
Gross proceeds from sale of renewal rights 30,000 28,000 0
Net cash provided by (used for) investing activities 80,134 (64,519) 174,585
Cash flows from financing activities:      
Net repayments under margin borrowing facility 0 0 (73,629)
Dividends / distributions paid to common shareholders (14,366) (14,431) (14,252)
Distributions paid to preferred shareholders (440) (440) (133)
Issuance of series A cumulative fixed rate preferred shares 0 0 4,000
Purchases of class A common shares (22,335) (490) (153)
Issuance of class A common shares 3,339 0 0
Redemption of subordinated notes (130,000) 0 (100,000)
Net cash used for financing activities (163,802) (15,361) (184,167)
Net change in cash and cash equivalents (39,432) 10,919 23,088
Cash and cash equivalents at beginning of period 78,278 67,359 44,271
Cash and cash equivalents at end of period $ 38,846 $ 78,278 $ 67,359